With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as an Advanced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.

Arens Taga is a neurologist specializing in neuromuscular diseases, with a particular focus on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. His clinical work aims to improve the quality of care for patients with ALS through biomarker-based, precision medicine approaches that refine disease stratification and facilitate more targeted and efficient enrollment in clinical trials. As a clinician-scientist, Dr. Taga uses patient-derived induced pluripotent stem cells to model ALS, uncover novel disease mechanisms and identify therapeutic targets that are translatable to clinical trials. In recognition of his work in ALS, Dr. Taga was awarded the 2025 Richard Olney Clinician Scientist Development Award, which honors early-career physician-scientists dedicated to advancing ALS research. Dr. Taga earned his medical degree from the School of Medicine and Surgery at the University of Parma, Italy, where he also completed his neurology residency. He subsequently trained at The Johns Hopkins University, completing a postdoctoral research fellowship in the neuromuscular division, an internal medicine internship, a neurology residency and a neuromuscular clinical fellowship. Dr. Taga is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Cluster Headache.

Dr. Probasco is a professor at the Johns Hopkins University School of Medicine Department of Neurology. He is the Vice Chair for Quality, Safety, and Service for the department. He also serves as the Director of the Johns Hopkins Division of Advanced Clinical Neurology as well as the Medical Director of the Johns Hopkins Inpatient General Neurology Service. He co-directs the Johns Hopkins Encephalitis Center and the Johns Hopkins Center for Refractory Status Epilepticus and Neuroinflammation. He cares for general neurology inpatients and outpatients, specializing in autoimmune and paraneoplastic syndromes as well as neurological immune-related adverse events following immunotherapies for cancer. After completing his undergraduate studies in biochemistry at the University of New Mexico, Dr. Probasco attended the University of Oxford as a Rhodes Scholar and earned a second undergraduate degree in psychology, philosophy and physiology. He went on to earn his medical degree at the University of California, San Francisco. He completed an internship in internal medicine at Johns Hopkins Bayview Medical Center and a residency in neurology at Johns Hopkins, where he was the faculty liaison/executive chief resident. He went on to complete an instructorship in inpatient general neurology at Johns Hopkins. Dr. Probasco’s research interests include increasing care value through improving outcomes, incorporation of patient experience of disease and treatment, the efficiency of care delivery, and diagnostic test utilization in general and specifically in relation to autoimmune and paraneoplastic neurological syndromes, including encephalitis. Finally, he is interested in the management of neurological immune-related adverse events following immunotherapies for the treatment of cancer. Dr. Probasco has been recognized at the departmental, institutional, and national levels for teaching and clinical excellence, including the American Academy of Neurology’s A.B. Baker Teacher Recognition Award and the Frank L. Coulson, Jr. Award from the Johns Hopkins Medicine Miller-Coulson Academy of Clinical Excellence. He is a past graduate of the Johns Hopkins Armstrong Institute Resident Scholars (AIRS) program in Patient Safety and Quality. As a faculty member, he was inducted into the Miller-Coulson Academy of Clinical Excellence in 2019. He serves as Editor-in-Chief of NEJM Journal Watch Neurology. Videos The impact of COVID-19 on the Department of Neurology‚Äôs clinical care and medical education programs. Dr. Probasco is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Encephalitis, Anti-NMDA Receptor Encephalitis, Status Epilepticus, Creutzfeldt-Jakob Disease, and Gastrostomy.

Dr. Sun is an expert in both pediatric neurology and cerebrovascular neurology, with a special interest in pediatric and young adult stroke. She focuses on both acute care of stroke as well as longitudinal management of an array of neurologic conditions that affect children and young adults. Dr. Sun’s research focuses broadly on pediatric and young adult stroke, with emphasis on discovering the causes, treatments, and prevention of stroke in the young. More specifically, Dr. Sun is investigating novel monitoring and stroke prevention techniques in children with moyamoya disease, which is a rare disease that places affected children and young adults at high risk of stroke. The goal of Dr. Sun's research is to improve outcomes and quality of life of individuals affected by stroke and moyamoya disease. In addition to her clinical and research interests, Dr. Sun is the associate program director of the Child Neurology residency program at Johns Hopkins. After completing medical school at the Johns Hopkins University School of Medicine, Dr. Sun completed her pediatrics and neurology residency training at Johns Hopkins, and subsequently she completed a fellowship in Vascular Neurology/Stroke. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. Her top areas of expertise are Moyamoya Disease, Stroke, Stiff Person Syndrome, Thrombectomy, and Cerebral Artery Bypass Surgery.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Dr. Chua is an assistant professor in the Department of Neurology and Division of Movement Disorders at Johns Hopkins. He received his training at the University of Michigan, where he obtained medical and graduate degrees, then completed a residency in neurology and a combined clinical/research fellowship in movement disorders and neurodegeneration. Dr. Chua’s primary research interests are in neurodegenerative disease with a special focus on autophagy — an essential housekeeping process in cells that is particularly important for the health of neurons. Autophagy may provide a way to break down the buildup of toxic proteins found in neurodegenerative diseases, thereby forming the basis of new treatment strategies for these incurable conditions. He has received multiple research grants to support his work, including from the National Institute of Neurological Disorders and Stroke and the American Academy of Neurology (AAN). He is the primary author and co-author of multiple peer-reviewed scientific publications and online learning modules as part of the AAN. Dr. Chua is a contributing author to The Little Black Book of Neurology by Osama Zaidat, Alan Lerner and J. Douglas Miles, and he has been a peer reviewer for the scientific journals Autophagy, eLife and Neurobiology of Disease. He currently serves on the scientific advisory board for the Don't Forget Morgan Foundation, a private organization supporting research and outreach regarding the disease beta-propeller protein-associated neurodegeneration (BPAN). For more information about the Chua Lab, please visit https://chualab.jhmi.edu. Dr. Chua is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Primary Lateral Sclerosis, Parkinson's Disease, Movement Disorders, and Camptocormism.

James Bernheimer is a Neurologist in Baltimore, Maryland. Dr. Bernheimer is rated as an Advanced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Opsoclonus-Myoclonus Syndrome, Peripheral Neuropathy, Benign Rolandic Epilepsy, and Myasthenia Gravis.

Eric Aldrich, M.D., Ph.D. is the director of Inpatient Neurological Services and medical director of the Johns Hopkins Howard County Stroke Center. He does not currently see patients who are not in the hospital. At Johns Hopkins, Dr. Aldrich developed The Johns Hopkins Hospital Stroke Center and served as its medical director for 10 years. In addition, he was the physician adviser for the Department of Neurology. Between 2010 and 2016, he served as the vice president of medical affairs at Howard County General Hospital, also helping to establish its local stroke program. Dr. Aldrich is a strong advocate for improving the quality of care and life for stroke patients and their families. Dr. Aldrich is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Opsoclonus-Myoclonus Syndrome, and Generalized Tonic-Clonic Seizure.

Mohammad Khoshnoodi is a Neurologist in Baltimore, Maryland. Dr. Khoshnoodi is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Peripheral Neuropathy, Chronic Polyradiculoneuritis, Guillain-Barre Syndrome, and Miller-Fisher Syndrome.

Neil Porter is a Neurologist in Baltimore, Maryland. Dr. Porter is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Myasthenia Gravis, Mononeuritis Multiplex, Multiple Mononeuropathy, Riboflavin Transporter Deficiency Neuronopathy, and Gastrostomy.

Chandana Chauhan is a Neurologist in Baltimore, Maryland. Dr. Chauhan is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. Her top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy (SMA), and Spinal Muscular Atrophy Type 3.

Dr. Hilary E. Gwynn is an instructor on the medical staff at Kennedy Krieger Institute in the Division of Neurology and Developmental Medicine. She teaches medical trainees and provides patient care at the Center for Development and Learning and on the Pediatric Rehabilitation Unit. She is also the site coordinator for the Johns Hopkins pediatric resident developmental disabilities rotation at the Kennedy Krieger Institute. Dr. Gwynn earned her medical degree at the University of Maryland School of Medicine in Baltimore, Maryland in 2000 and completed her pediatrics residency there in 2003. She subsequently joined the Kennedy Krieger Institute in 2003 to attend the fellowship in neurodevelopmental disabilities through the Kennedy Krieger Institute and Johns Hopkins University School of Medicine. Since graduation from the fellowship program in 2007, she has been an active member of the medical staff at Kennedy Krieger Institute. She teaches medical trainees and provides patient care at the Center for Development and Learning and on the Pediatric Rehabilitation Unit. She is also a member of the clinical staff of the Department of Pediatrics at Johns Hopkins School of Medicine. Contact for Research Inquiries 801 N. Broadway Baltimore, MD 21205 Phone: (443) 923-3246 Research Summary Dr. Gwynn's clinical and research interests include diagnosis and treatment of the child with developmental disability. She is also investigating medical training methodology as it applies to resident and fellow training in the practice of developmental medicine and child neurology. Dr. Gwynn is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. Her top areas of expertise are Cerebral Palsy, Focal Dystonia, Spastic Diplegia Infantile Type, and Moebius Syndrome.

Shannon Dean is a Neurologist and a Pediatric Neurologist in Baltimore, Maryland. Dr. Dean is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. Her top areas of expertise are Stereotypic Movement Disorder, Tourette Syndrome, Transient Tic Disorder, and Conversion Disorder.

Dr. George Ricaurte has a weekly clinic that focuses on Parkinsons disease and other movement disorders. In addition, he attends on the consult and in-patient neurology services at Johns Hopkins Bayview Medical Center. Dr. Ricaurte's research interests center on amphetamine-type stimulants and their potential to damage brain monoamine-containing neurons, including dopamine neurons (which degenerate in Parkinsons disease). Dr. Ricaurte and his colleagues are particularly interested in mechanisms of dopamine nerve cell degeneration. The long-term goal of this neurotoxicology research is to help find ways to prevent - or retard - the progression of Parkinsons disease and related neurodegenerative disorders. Dr. Ricaurtes work also has implications for the drug abuse field and substance abuse neuropsychiatric disorders. Dr. George Ricaurte received his medical degree from Northwestern University Medical School and his doctorate in Pharmacology from the University of Chicago. He then completed his residency in neurology at Stanford University Medical Center and did a one year fellowship at the Parkinsons Institute in California. Dr. Ricaurte is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Essential Tremor.

Zhaoming Chen is a Neurologist in Baltimore, Maryland. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Periodic Limb Movement Disorder, and Peripheral Neuropathy.

Mark Fehr is a Neurologist in Baltimore, Maryland. Dr. Fehr is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Memory Loss, Seizures, Partial Familial Epilepsy, and Generalized Tonic-Clonic Seizure. Dr. Fehr is currently accepting new patients.

Haopeng Zheng is a Neurologist in Baltimore, Maryland. Dr. Zheng is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Migraine, Headache, Memory Loss, and Increased Intracranial Pressure. Dr. Zheng is currently accepting new patients.

Stephen Reich is a Neurologist in Baltimore, Maryland. Dr. Reich is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. His top areas of expertise are Movement Disorders, Parkinson's Disease, Supranuclear Ophthalmoplegia, Deep Brain Stimulation, and Gastrostomy. Dr. Reich is currently accepting new patients.

Lisa Shulman is a Neurologist in Baltimore, Maryland. Dr. Shulman is rated as an Experienced provider by MediFind in the treatment of Opsoclonus-Myoclonus Syndrome. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Benign Essential Blepharospasm. Dr. Shulman is currently accepting new patients.